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Abstract
Background: Brain tumour patients see their primary care doctor on average three or more times before diagnosis,
so there may be an opportunity to identify ‘at risk’ patients earlier. Suspecting a brain tumour diagnosis is difficult
because brain tumour-related symptoms are typically non-specific.
Methods: We explored the predictive value of referral guidelines (Kernick and NICE 2005) for brain imaging where
a tumour is suspected, in a population-based patient group referred for direct access CT of the head. A consensus
panel reviewed whether non-tumour findings were clinically important or whether further investigation was necessary.
Results: Over a 5-year period, 3257 head scans were performed; 318 scans were excluded according to pre-specified
criteria. 53 patients (1.8%) were reported to have intracranial tumours, of which 42 were significant (diagnostic yield of
1.43%). There were no false negative CT scans for tumour. With symptom-based referral guidelines primary care
doctors can identify patients with a 3% positive predictive value (PPV). 559 patients had non-tumour findings, 31% of
which were deemed clinically significant. In 34% of these 559 patients, referral for further imaging and/or specialist
assessment from primary care was still thought warranted.
Conclusion: Existing referral guidelines are insufficient to stratify patients adequately based on their symptoms,
according to the likelihood that a tumour will be found on brain imaging. Identification of non-tumour findings may
be significant for patients and earlier specialist input into interpretation of these images may be beneficial. Improving
guidelines to better identify patients at risk of a brain tumour should be a priority, to improve speed of diagnosis, and
reduce unnecessary imaging and costs. Future guidelines may incorporate groups of symptoms, clinical signs and tests
to improve the predictive value.
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Background
People with a brain tumour see their primary care
doctor on average 3 or more times before diagnosis [15],
so there may be an opportunity to identify ‘at risk’
patients earlier. Patients with alarming ‘high-risk’ symp-
toms such as focal neurological deficit caused by a brain
tumour are usually diagnosed quickly, either through an
emergency department or via urgent referral to a
specialist clinic (e.g. TIA/stroke clinic). By contrast, pa-
tients with more common and lower-risk symptoms
(such as headache, cognitive or personality changes, or a
combination of these) are most diagnostically challen-
ging and may experience their symptoms for several
weeks before specialist referral [21]. The rarity of this
diagnosis means possible cases will usually have another
less serious cause.
In the UK, only 1% of adult brain tumours are
diagnosed through a “suspicion of cancer” secondary
care pathway requiring patients to be seen within 2
weeks of referral [7]. This is one of the lowest of all
cancers and is not improving. More adult brain tumours
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(35%) are diagnosed through routine secondary care out-
patient referral pathways [7]. In all likelihood the symp-
toms in the majority of these brain tumour patients
were insufficient to prompt an urgent cancer referral
request.
Guidelines exist to support primary care doctors in
identification of patients at risk of having a brain tumour
to guide who should be prioritised for urgent brain im-
aging. Kernick and colleagues’ symptom-based guide-
lines [12] utilise a flag (red/orange/yellow) system that
reflects three levels of risk for brain tumour, with em-
phasis on headache presentations. The National Institute
of Health and Care Excellence, (NICE), also developed
referral guidelines for adults with suspected CNS cancer.
The 2005 [19] guidance was based on groups of symp-
toms that should precipitate urgent specialist outpatient
assessment, typically within 2 weeks. In 2015 [20] the
guidelines were simplified to recommend direct access
MRI scan within 2 weeks in adults with progressive, sub-
acute loss of central neurological function. The 2015
guideline did not provide guidance for patients with
other (e.g. cognition, headache) symptoms.
Our objective was to explore the predictive value of
the Kernick and NICE 2005 referral guidelines. To do
this we investigated the predictive ability of these
current referral guidelines to identify patients with a
brain tumour when applied to a population-based
patient group referred for direct access CT of the head
from primary care. We wanted to determine if there was
scope for current referral guidelines to be optimised to
improve identification of patients in primary care most
likely to have a brain tumour based on their symptoms,
in order to expedite urgent brain imaging.
Methods
The Lothian region of South East Scotland serves a
population of 840,000. Since 1999 primary care doctors
in Lothian have had direct access to outpatient com-
puted tomography (CT) brain imaging via a single refer-
ral pathway, for the exclusion of significant intracranial
pathology. This is a group of patients whom the refer-
ring primary care doctor did not consider needed urgent
brain imaging.
We identified patients aged 16 years or older referred
for direct access CT (DACT) between 31 March 2010
and 1 April 2015 from a local electronic database (Fig. 1).
All information provided by primary care doctors on the
DACT referral was extracted verbatim; the referral is
non-structured and there is no minimum dataset. We
excluded patients referred for scanning after head
trauma to rule out haematoma, those patients with
known brain tumour receiving surveillance scans, and
where there was no clinical information on the referral
form or other electronic sources. All CT head scans
were performed in the neuroradiological department at
the Department of Clinical Neurosciences, Western
General Hospital, Edinburgh, Scotland and reported by a
Consultant Neuro-radiologist.
The Kernick referral criteria (Table 1) present 3
symptom groups, where red flag symptoms indicate the
probability of an underlying tumour is ≥1%, orange flag
symptoms that the probability is between 0.1 and 1%,
and yellow flag symptoms indicate a probability of less
than 0.1%, but above the population rate of 0.01%. The
2005 NICE referral guidelines included details of symp-
toms that should prompt urgent referral, consideration
of urgent referral, or non-urgent referral (Table 2). In
these guidelines we anticipated that ‘headache of raised
intracranial pressure’ from the “refer urgently” category
may not be associated with an equivalent risk of a brain
tumour to ‘symptoms related to the CNS’ and, therefore,
we subdivided these into separate categories (Table 2).
This allowed a more accurate comparison of symptom
complexes at risk for brain tumour.
Presenting symptoms indicated by the primary care
referral were individually recorded and assigned to one
of these symptom categories in both the NICE and
Kernick referral guidelines independently by a junior
doctor and a senior medical student (KZ and CI). A
Lothian DACT referral is an open text referral through
an electronic platform. The referring primary care
doctor can write as little or as much information as they
feel is necessary. If a symptom appeared in more than
one category of the referral guidelines, and the informa-
tion provided about the presenting symptom was
inadequate to assess its severity or characteristics, it was
ascribed to the lowest possible category of urgency in
the referral guidelines. For example, in the case of
‘headache’ symptom with no qualifying information, the
symptom would be recorded as the non-urgent category
in the NICE referral guidelines.
If there was disagreement as to which referral guide-
line category the presenting symptom should be ascribed
to, one of the other authors (PB), a consultant neurosur-
geon, made the final judgement. The radiological inter-
val was determined as the time from the date of referral
for DACT to the date of brain imaging.
Radiology reports for each patient were categorised by
KZ into one of three groups according to the findings
reported by the consultant radiologist: 1) abnormal
significant - intracranial tumour 2) abnormal significant
- non-tumour and 3) normal/non-significant incidental
finding. All scan reports where the imaging was not
reported as ‘normal’ were reviewed by a consultant
neurosurgeon, (PB), to assess whether the abnormality
identified was likely to be significant in the context of
the referral history. This assessment was based on the
likely diagnosis (e.g. tumour), the size and location of
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the abnormality, and/or whether the abnormality was
thought likely to be responsible for the presenting symp-
toms, considering any opinion reported by the consult-
ant neuroradiologist. Where necessary, the images were
reviewed. Findings were considered ‘significant’ if clinical
details correlated with imaging findings, or if the im-
aging findings alone were suggestive of requiring further
investigations irrespective of the symptoms. Findings
were considered ‘non-significant’ if they were reported
as within normal limits for age (e.g. some degree of
atrophy or small vessel disease) or were not related to
the presenting symptom(s) recorded on the referral.
For all patients where a tumour was not diagnosed on
imaging, we determined whether within the duration of
the study there was evidence of a tumour diagnosis. We
did this by examining all neuro-oncology multidisciplin-
ary meeting (MDM) minutes for the same 5-year time-
period at Edinburgh Centre for Neuro-Oncology
(ECNO), and any subsequent imaging reports on the
patient’s electronic health record, for a minimum of
three years.
Confirmation of CNS tumour diagnosis was based on
histopathology for all significant tumours.
We assessed how the imaging report might have
influenced the referring primary care doctor. Three
practising primary care doctors, (WHa, based in
England, LP and DW based in Scotland) reviewed
‘abnormal’ imaging reports alongside the accompanying
Fig. 1 Flow chart of identification and analysis of included referrals
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referral text and determined a potential action plan for
follow-up according to the classification system in
Table 3. We examined the management plans according
to whether the symptom met the NICE 2005 guidelines
for urgent or non-urgent referral.
Statistical methods
To examine the diagnostic performance of the imaging/
referral guidelines we calculated the diagnostic odds ra-
tios using a logistic regression model for the presence of
CNS tumour. Gender and age were considered as con-
founding variables and were adjusted for in the logistic
regression model. Correlation between NICE 2005 and
Kernick’s referral guideline symptom categories was
analysed using the weighted kappa statistic. A fre-
quency table was created of the ‘abnormal’ findings
reported, and of the action plan determined by the
primary care doctor. The level of statistical signifi-
cance was set at p < 0.05. The data were analysed
using Stata/MP 14.2.
Results
Over a 5-year period, 3256 head scans were performed.
After excluding 318 scans according to pre-specified
criteria (see Fig. 1 flowchart), 2938 records were
reviewed. The mean age was 55.6 years (SD = 18.56) and
there were more females (1748, 60%); Table 4.
Assessors agreed as to categorisation of the presenting
symptom in 97% of referrals. From 2938 scans, 53
patients (1.8%) had intracranial tumours reported, of
which 42 were significant (diagnostic yield of 1.43%).
Eleven tumours were thought to be incidental, unrelated
to symptom(s) precipitating referral, and likely to be be-
nign meningiomas based on the radiological appearance.
None of these patients proceeded to surgery within the
time course of the study. No patient without intracranial
tumour on the DACT imaging report was subsequently
identified to have a tumour on imaging within the study.
Of the significant tumours, 17/42 (40%) patients had
metastases, 8/42 (19%) pituitary tumours, 7/42 (17%)
meningiomas, 5/42 (12%) glioblastoma multiforme
(GBM), 4/42 (10%) non-GBM glioma, and 1/42 (2%) a
CNS lymphoma.
Brain tumours occurred in each of the Kernick
categories with the expected frequencies: red flag 3.7%
(expected > 1%), orange flag 0.7% (expected 0.1 to 1%)
and yellow flag 0.09% (expected 0.01 to < 0.1%) (Table 5).
Kernick’s red-flag group was the only one with a signifi-
cantly increased risk of brain tumour (OR 5.73, 95% CI
2.21–14.84) (Table 5). Using the NICE 2005 referral
guidelines, ‘symptoms related to CNS’ had significantly
elevated odds ratio for presence of a brain tumour (OR
5.21, 95% CI 1.81–14.92) compared to the symptoms
recommended for non-urgent referral (Table 6).
If the tumours we deemed incidental were instead
included in the analysis, the OR for red flag symptoms
reduced to 3.86 (1.78–8.38) and for orange symptoms
increased to 1.46 (0.56–3.85). For the NICE 2005 cat-
egories, the odds ratios changed to 3.59 (1.5–8.7), 1.9
(0.63–5.69), and 0.54 (0.13–2.2) for CNS, raised ICP and
subacute groups, respectively.
Frequency of non-tumour radiological diagnosis
Five hundred fifty-nine (19.2%) scans reported a non-
tumour finding (Table 7). 177 (31.7%) of these findings
were considered significant based on patient symptoms
and radiological opinion. Cerebral atrophy (45.8%),
vascular abnormalities (27.1%) and sinus disease (13.6%)
were the most common significant findings.
We examined how well the Kernick and NICE 2005
referral guidelines performed at identifying all significant
abnormalities, including brain tumours. The odds ra-
tio for red flag symptoms was 0.7 (0.5–0.9) and for
orange symptoms 0.38 (0.25–0.58). For the NICE
2005 categories, the odds ratios changed to 2.4 (1.5–
3.9), 1.57 (0.85–2.9), and 4.76 (2.88–7.87) for CNS,
raised ICP and subacute groups, respectively. This
indicates a worse performance for all categories
Table 1 “Kernick’s” primary care guidance for imaging patients
with suspected brain tumour
Red flag symptoms
▪ Papilloedema
▪ significant alterations in consciousness, memory, confusion, or
coordination
▪ new epileptic seizure
▪ new onset cluster headache
▪ headache with a history of cancer elsewhere particularly
breast and lung
▪ headache with abnormal findings on neurological examination or
other neurological symptoms
Orange flag symptoms
▪ new headache where a diagnostic pattern has not emerged
after 8 weeks from presentation
▪ headache aggravated with exertion or Valsalva-like manoeuvre
▪ headache associated with vomiting
▪ headache that has been present for some time but have changed
significantly, particularly a rapid increase in frequency
▪ new headache in patient over 50 years
▪ headache that wake the patient from sleep
▪ confusion
Yellow flag symptoms
▪ diagnosis of migraine or tension-type headache
▪ weakness or motor loss
▪ memory loss
▪ personality change
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except for subacute symptoms in the NICE referral
guidelines, when compared with the performance for
identifying only brain tumours.
Management of radiological findings in primary care
We determined possible management of the 559 patients
with non-tumour findings in primary care from the
available referral history and CT brain imaging findings
(Table 8).
18.6% of imaging abnormalities were determined to
require no further follow-up but did explain the patient’s
presenting symptom. 38.4% of radiologically reported
Table 2 NICE 2005 guidelines on specialist referral
Refer urgently Symptoms related to the CNS, including
▪ progressive neurological deficit
▪ new-onset/suspected recent onset seizures
▪ headaches
▪ mental changes
▪ cranial nerve palsy
▪ unilateral sensorineural deafness
in whom a brain tumour is suspected
Headache of recent onset accompanied by features suggestive of raised intracranial pressure, for example:
▪ vomiting
▪ drowsiness
▪ posture-related headache
▪ pulse-synchronous tinnitus
▪ or by other focal or non-focal neurological symptoms, for example blackout, change in personality or memory
▪ a new, qualitatively different, unexplained headache that becomes progressively severe
Consider urgent referral Patients with rapid progression of:
▪ sub-acute focal neurological deficit
▪ unexplained cognitive impairment, behavioural disturbance or slowness, or a combination of these
▪ personality changes confirmed by a witness and for which there is no reasonable explanation even in
the absence of other symptoms and signs of a brain tumour
Consider non-urgent referral Patients with:
▪ unexplained headaches of recent onset: either present for at least 1 month, or not accompanied by
features suggestive of raised ICP
Table 3 Potential action plan suggested by GPs based on direct
access head imaging
1 Normal - does NOT explain the presenting symptom(s)
2 Abnormal, but not requiring further investigation - explains the
presenting symptom(s) and can be managed in primary care
3 Abnormal, but not requiring further investigation - does NOT explain
the presenting complaint, but can be managed in primary care
4 Abnormal, requiring further investigation (such as follow up scans or
referral), but NO suspicion of tumour
5 Tumour suspected, requiring referral/follow-up
Table 4 Baseline demographics for patients investigated with
direct access CT head imaging over 5-year period (N = 2938)
Patient variable Significant Brain tumour
All Present (n = 42)
Gender
Female, N (%) 1748 (60) 23 (55)
Age (years)
Mean, SD 55.6 (18.56) 60.2 (14.38)
Age group in years, N (%)
16–29 335 (11.4) 1 (2.4)
30–39 287 (9.8) 1 (2.4)
40–49 436 (14.8) 9 (21.4)
50–59 547 (18.6) 6 (14.3)
60–69 567 (19.3) 15 (35.7)
70–79 464 (15.8) 7 (16.6)
80+ 302 (10.3) 3 (7.1)
Radiological interval (days)
Mean [95% CI] 17.3 [16.9,17.6] 14.6 [12.4,16.7]*
*statistically significant difference (t-test), p = 0.05
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abnormalities did not explain the patient’s presenting
symptoms, but care could be managed in primary care.
34.2% of patients required referral for further imaging or
specialist assessment. 38.7% of referrals with an imaging
abnormality that met the NICE 2005 ‘non-urgent
classification’ would still have been referred for further
imaging or specialist opinion.
We performed a cross tabulation to compare the
three principal categories of NICE and Kernick referral
guidelines based on recommended speed of referral
(Table 9). Whilst 100% of Kernick red flag cases were also
classified as refer urgently according to the NICE 2005
guidance, there was overall quite a lot of disagreement
and the weighted kappa showed only modest agreement
beyond chance (0.33). This highlights that the different
referral guidelines are making different management
recommendations for any given symptom.
Discussion
Summary
Our study is the first to examine the diagnostic utility of
both the NICE 200519 and Kernick [12] guidelines in a
population-based patient group and to consider the
relevance of significant non-tumour pathology.
The availability of direct primary care access to brain
imaging (DACT) varies across the UK. In areas where it
is available the Kernick and NICE guidelines may be
used to inform referral decisions. Broadly, based on
symptoms (red flags or NICE 2005 ‘symptoms related to
the CNS’) primary care doctors can identify patients
who have a brain tumour with a 3% PPV. Nearly 80% of
patients whose CT revealed a brain tumour had ‘symp-
toms related to the CNS’ on NICE 2005 or Kernick’s
red-flag symptoms. Overall, the Kernick system
performed as predicted [12].
Nineteen percent of scans reported non-tumour
findings, 18.6% of these non-tumour findings were
thought by primary care doctors to explain the patient’s
symptoms. One third of patients with a non-tumour ab-
normal finding were judged to require onward specialist
referral. Access to DACT will influence management of
more patients who do not have brain tumours than
those that do. Most significant non-tumour findings fall
into Kernick’s yellow flag group, and into the sub-acute
focal deficits of NICE, so DACT should not be restricted
to the ‘refer urgently’ and red-flag symptom categories.
Further, whether patients with lower prevalence
symptoms (e.g. yellow and orange flags) might also
benefit through faster ruling in or out of cancer and the
diagnosis of other pathology, and whether this is justified
by the cost and potential harm (radiation and over
diagnosis) of CT, requires further study.
Whilst existing referral guidelines may meet their
intended threshold of specificity, these guidelines are
insufficient to adequately stratify patients. Moreover, the
different referral guidelines make different management
recommendations in terms of urgency for some symp-
toms. For example, all of the Kernick red flags are also
in NICE refer urgently, but 30% of NICE refer urgently
are either in Orange and even a few in Yellow flags.
Table 5 Frequency of tumours from direct access CT grouped based on Kernick referral criteria. Odds ratio with 95% CI for each flag
symptom, for the presence of a brain tumour
Brain tumour
Total Absent Present
Freq % Freq % Odds ratio 95% CI PPV
Red flag symptoms 1141 1109 92 32 3.7 5.73 2.21–14.84 2.8
Orange flag symptoms 728 723 99 5 0.7 1.34 0.38–4.68 0.7
Yellow flag symptoms 1069 1064 99 1 0.09 reference 0.5
Adjusted for age and sex. An odds ratio of 1.0 indicates the odds of exposure among case-patients are the same as, or similar to, the odds of exposure
among controls
Table 6 Frequency of referrals for direct access CT grouped based on clinical criteria from NICE 2005 guidelines. Odds ratio with
95%CI/PPV for each criteria of NICE 2005 guidelines for the presence of a brain tumour
Brain tumour
Total Absent Present
Freq % Freq % Odds ratio 95% CI PPV
Symptoms related to the CNS 1150 1117 97 33 3.0 5.21 1.81–14.92 2.9
Headache & features of raised ICP 473 469 99 4 1 1.65 0.41–6.67 0.8
Sub-acute deficits focal/personality/cognitive/behavioural 525 524 99 1 < 1 0.31 0.03–2.79 0.2
Simple headache 790 786 99 4 1 reference 0.5
Adjusted for age and sex. An odds ratio of 1.0 indicates the odds of exposure among case-patients are the same as, or similar to, the odds of exposure
among controls
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These referral guidelines are recommending quite differ-
ent decisions for some patients, reflecting the evidence
that any individual patient symptom is poorly predictive
of a brain tumour [21]. This is important, because ineffi-
cient guidelines crowd the referral system, adding to
delay in diagnosis for those patients who do have a brain
tumour. Whether more liberal DACT criteria is a good
use of NHS money requires further research.
Strengths and limitations
This is the largest reported population-based study of
primary care imaging referrals for suspected intracra-
nial abnormality. Grouping was performed by two au-
thors, and a third where necessary, to increase
accuracy. All scans were performed at a single clinical
neuro-sciences centre and were reported by a consult-
ant neuro-radiologist. As this was part of a retro-
spective study it allowed sufficient follow-up to
record false negatives for a brain tumour with respect
to the initial diagnostic CT scan; we did not identify
any. A strength is that we examined scan utility in
patients with non-tumour pathology, based on a con-
sensus opinion. Despite the large number of referrals
that yield of brain tumour cases was not large, hence
we have imprecise estimates for our odds ratios.
Many patients with sudden onset symptoms that
precipitate immediate hospital assessment at an
emergency department will also fall into the Kernick
red flag category. Our approach therefore underesti-
mates the predictive ability of the Kernick system in
the whole brain tumour population, although our
data does reflect the situation in primary care when
uncertainty about a brain tumour diagnosis exists.
Table 7 Frequency of non-tumour findings on direct access CT
imaging
Abnormality Frequency
Total Significant (%)
Cerebral atrophy 206 81 (39.3)
Vascular 195 48 (24.6)
Sinus disease 58 24 (48.0)
Arnold Chiari malformation type
1/tonsillar ectopia
27 9 (33.3)
Benign cystic lesion 20 2 (10.0)
Ventricular abnormality 11 8 (72.7)
ENT tumour 4 1 (25.0)
Other 38 4 (10.5)
Total 559 177 (31.1)
Table 8 Frequency table action plan by primary care doctor for reported non-tumour findings from direct access head imaging, N (%)
Normal - does
NOT explain
the presenting
symptom(s)
Abnormal, but not requiring
further investigation - explains
the presenting symptom(s) and
can be managed in primary care
Abnormal, but not requiring further
investigation - does NOT explain
the presenting complaint, but can
be managed in primary care
Abnormal, requiring further
investigation (such as follow
up scans or referral), but NO
suspicion of tumour
Tumour
suspected,
requiring
referral/
follow-up
Cerebral
atrophy
12 (5.8) 53 (25.7) 76 (36.9) 65 (31.6) 0
Ventricular
abnormality
1 (9.8) 1 (9.8) 5 (45.5) 4 (36.4) 0
Benign cystic
lesion
0 2 (10) 6 (30) 12 (60) 0
Sinus disease 7 (12.1) 9 (15.5) 23 (39.7) 19 (32.8) 0
Arnold Chiari
malformation
type 1/
tonsillar
ectopia
5 (18.5) 2 (7.4) 12 (44.4) 8 (29.6) 0
ENT lesion 0 0 3 (75) 1 (25) 0
Vascular 12 (6.2) 37 (19) 74 (37.9) 72 (36.9) 0
Other 7 (18.4) 2 (5.3) 15 (39.5) 14 (36.8) 0
Total 44 (7.7) 106 (18.6) 219 (38.4) 195 (34.2) 6 (1.1)
NICE
category:
Urgent
referral (N, %)
35 (6.5) 97 (18) 195 (36.2) 172 (32) 39 (7.2)
NICE
category:
Non-Urgent
(N, %)
9 (12) 9 (12) 24 (32) 29 (38.7) 4 (5.3)
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Implications for practice and research
The non-specificity of many symptoms associated with
brain tumours makes it difficult to identify patients to
prioritise for brain imaging. Our data demonstrates that
existing guidelines provide some assistance to the pri-
mary care doctor. We utilised the 2005 NICE guidelines
because they provided a greater granularity of patient
symptoms than 2015 guidelines. Since we demonstrated
that only ‘symptoms related to CNS’ is a useful predictor
of whether or not a patient may have a brain tumour,
the simplification in 2015 may be justified.
A relatively large proportion of our patients were
referred for headache only (26.9%). Certain headache
features may raise suspicion of an underlying brain
tumour [2], but are still not specific [22]. We previously
demonstrated that patients with non-specific symptoms
such headache, cognitive changes or personality changes
are subjected to the longest delay from onset of symp-
toms to brain tumour diagnosis [21]. Combining these
symptoms may help identify patients to prioritise for
brain imaging [21], but this must be balanced against
the ‘risk’ of detecting pathology incidental to the clinical
presentation.
In our cohort, there were no false-negative results.
The NICE 2015 guidelines recommend cranial MRI
for suspected brain tumour in patients with progressive
sub-acute loss of central neurological function (CT only
if MRI contra-indicated). The low uptake of imaging for
brain tumours in primary care compared to other
cancers [6] may in part reflect variation in access to
brain imaging. There are fewer MRI scanners in the UK
than almost any other Western European country [16].
Our data suggest CT imaging may be adequate as a test
in patients deemed at risk of a brain tumour based on
headache symptoms. CT is the standard initial imaging
modality for patients with acute onset focal stroke-like
symptoms [5] and is not diagnostically inferior in identi-
fying clinically significant pathologies for non-acute
headache presentation [8, 11]. Cranial CT costs less and
is more readily available than MRI. MRI might be re-
served for specific patients, such as those with new onset
seizures, where a radiologically subtle low-grade tumour
is more likely [26]. Potential risks of ionising radiation
are sometimes cited to recommend MRI over CT, al-
though an individual patient’s risk is small [24]. It is pro-
jected that 1 in 8100 women aged 40 years will develop
cancer from a single head CT [24]. The risks may be
doubled for 20-year-olds [24] so It may be necessary to
prioritise MRI in younger patients.
Comparison with other studies
Our diagnostic yield of the referral guidelines for a
significant brain tumour was 1.43%, slightly higher than
that reported by Benamore [3] (for any symptom
presentation - 1.28%) or Simpson [23] (for symptom of
headache only - 0.5%), both with open access CT.
For some patients a negative scan for a brain tumour
provides reassurance [1, 10]. Incidental findings are not
uncommon, even in asymptomatic patients, and can
result in additional patient worry, investigations and cost
[3, 4, 11, 18]. Nearly a fifth of all scans in our study iden-
tified a non-tumour finding, similar to patients referred
Table 9 Cross Tabulation of symptoms within Kernick and NICE 2005 referral guidelines based on recommended speed of referral
NICE 2005 categories
Refer Urgently Consider urgent referral Non-urgent referral Total
Kernick Red Flag Count 1141 0 0 1141
% within Kernick 100.0 0.0 0.0 100.0
% within NICE 70.3 0.0 0.0 38.8
% of total 38.8 0.0 0.0 38.8
Orange Flag Count 468 4 256 728
% within Kernick 64.3 0.5 35.2 100.0
% within NICE 28.8 0.8 32.4 24.8
% of total 15.9 0.1 8.7 24.8
Yellow Flag Count 14 521 534 1069
% within Kernick 1.3 48.7 50.0 100.0
% within NICE 0.9 99.2 67.6 36.4
% of total 0.5 17.7 18.2 36.4
Total Count 1623 525 790 2938
% within Kernick 55.2 17.9 26.9 100.0
% within NICE 100.0 100.0 100.0 100.0
% of total 55.2 17.9 26.9 100.0
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for imaging with any symptom [3, 17] or headache only
[11]. 18.6% of our non-tumour findings likely explained
the symptoms precipitating referral, although the inci-
dence of significant cerebral atrophy may have been
overstated, because we performed qualitative estimation
of atrophy, which is known to have inter-rater variability
[14]. For two thirds of abnormal radiological findings,
primary care doctors in our study would be confident to
manage patients in primary care, reflecting other reports
[3, 11]. In keeping with previous findings [3], CT for
‘simple’ headache (“non-urgent” category according to
NICE 2005) may require further follow-up or additional
investigation in 38.7% of cases where a non-tumour
abnormality is found.
Primary care doctors often report difficulty interpret-
ing neuro-radiological reports, particularly incidental ab-
normalities [25], and find radiologists’ recommendations
for further treatment, referral or non-radiological inves-
tigation valuable [9]. There is no agreed consensus
among radiologists on reporting of incidental findings
and/or recommending follow-ups. Primary care doctors
rely on their judgement interpreting and relaying these
reports to patients, which may cause anxiety for the pri-
mary care doctor and lead to additional referrals [13]. A
recent qualitative prospective study with 20 GPs identi-
fied a need for standardised reporting of scans to im-
prove GP’s use of direct-access MRI [25], which may
also be appropriate for CT scans.
Conclusions
Guidelines should provide an evidence-base to assist
primary care doctors in identifying patients most at risk
of having a brain tumour (i.e. diagnostic accuracy), but
also the fastest route to achieve diagnosis (e.g. direct
access imaging versus urgent secondary care referral).
Direct access CT scanning has a low false negative rate.
However, existing referral guidelines are insufficient to
adequately stratify patients based on their symptoms ac-
cording to the likelihood that a tumour will be identified
on brain imaging. Improving guidelines to better identify
patients at risk of a brain tumour should be a priority, to
improve speed of diagnosis, and reduce unnecessary
imaging and costs. Future guidelines may need to in-
corporate groups of symptoms, clinical signs and tests to
improve the predictive value. In patients referred for
DACT, identification of non-tumour findings may be
important for patients. Earlier specialist input into inter-
pretation of these non-tumour abnormality images may
be warranted and appreciated.
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